← Leaderboards
Shanna Babalonis
University Of Kentucky
$4,991,850
Attributed
$4,991,850
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $799.4K · FY2007–24$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,991,850 · 4
By mechanism
R01$4,474,456 · 2
R21$410,712 · 1
R36$106,682 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Joshua Anthony Lile$8,940,358
- Craig R Rush$27,535,139
- Rick S. Zimmerman$14,475,195
- Dustin Clark Lee$2,599,329
- Sharon L. Walsh$101,480,172
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsDesignPhysiologicalDoseStatutes And LawsCannabinoidsSamplingMarijuana UseReportingRandomizedEnrollmentAcutePublic HealthMedical MarijuanaPlacebosSafetyAffectMarijuanaOpioid OverdoseAgonistOpioid UseOpioid MisuseOpioidOpioid Mortality
Grant awards (11)
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Opioid Abuse Potential and Opioid Safety$695,760
R01 · FY2024 · DA · contact PI
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Opioid Abuse Potential and Opioid Safety$709,013
R01 · FY2023 · DA · contact PI
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Opioid Abuse Potential and Opioid Safety$720,687
R01 · FY2022 · DA · contact PI
Evaluation of Marijuana and Opioid Drug Interactions: Assessment of the Safety Profile, Abuse-Related Pharmacodynamic Effects and Models of Drug Intake$609,253
R01 · FY2021 · DA · contact PI
Evaluation of Marijuana and Opioid Drug Interactions: Assessment of the Safety Profile, Abuse-Related Pharmacodynamic Effects and Models of Drug Intake$609,302
R01 · FY2020 · DA · contact PI
Evaluation of Marijuana and Opioid Drug Interactions: Assessment of the Safety Profile, Abuse-Related Pharmacodynamic Effects and Models of Drug Intake$555,524
R01 · FY2019 · DA · contact PI
Evaluating Recreational and Medical Marijuana Strains for Impairing Effects on Simulated Driving Performance$186,231
R21 · FY2019 · DA · contact PI
Evaluation of Marijuana and Opioid Drug Interactions: Assessment of the Safety Profile, Abuse-Related Pharmacodynamic Effects and Models of Drug Intake$574,917
R01 · FY2018 · DA · contact PI
Evaluating Recreational and Medical Marijuana Strains for Impairing Effects on Simulated Driving Performance$224,481
R21 · FY2018 · DA · contact PI
Separate and Combined Effects of Progesterone and Triazolam in Healthy Women$52,763
R36 · FY2008 · DA · contact PI
Separate and Combined Effects of Progesterone and Triazolam in Healthy Women$53,919
R36 · FY2007 · DA · contact PI